EPIX Medical Inc. filed its first new drug application along with partner, Schering AG, for a blood-pool agent called MS-325 for vascular imaging with magnetic resonance angiography. (BioWorld Today)

Acambis plc filed a biologics license application seeking approval of Arilvax as a vaccine to prevent yellow fever. (BioWorld International)

Acambis plc filed a biologics license application seeking approval of Arilvax as a vaccine to prevent yellow fever. (BioWorld International)

EPIX Medical Inc. filed its first new drug application along with partner, Schering AG, for a blood-pool agent called MS-325 for vascular imaging with magnetic resonance angiography. (BioWorld Today)